In a report released today, Aaron Hecht from JMP Securities maintained a Hold rating on AFC Gamma (AFCG – Research Report). The company’s shares closed last Friday at $6.62. Easily identify ...

The Abingworth-backed biotech is developing therapies based on the unique properties of gamma delta (γδ) T cells, a class of lymphocytes that play a role in a host of immune responses and ...